Studies have demonstrated that the loss of p53 function in cutaneous T-cell lymphoma (CTCL) can impact various cellular processes, including cell cycle control and DNA repair, leading to the resistance of CTCL cells to chemotherapy31. This evidence concerns the gene TP53 and primary cutaneous T-cell non-Hodgkin lymphoma.